Viewing Study NCT01723657


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2026-01-20 @ 1:31 AM
Study NCT ID: NCT01723657
Status: COMPLETED
Last Update Posted: 2012-11-08
First Post: 2012-10-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML)
Sponsor: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myelocytic, Acute View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Myeloid View
None Acute View
None Young View
None CETLAM View